Business Overview: Pediatrix Medical Group, Inc. (NYSE: MD)

---

Executive Summary

Pediatrix Medical Group (formerly Mednax) is the largest U.S. physician services organization focused on neonatal and maternal-fetal medicine, staffing and managing neonatal intensive care units (NICUs) at hundreds of hospitals nationwide. Its business model is built on being the indispensable, always-available clinical staffing partner for a medical specialty that individual hospitals — particularly smaller and mid-sized ones — cannot economically recruit, schedule, or manage on their own. Over the past several years the company has deliberately shed non-core, lower-margin office-based practice lines (outside maternal-fetal medicine) to refocus on its core hospital-based neonatal and maternal-fetal franchise, a strategy that materially changes its risk and growth profile relative to its earlier, more diversified physician-services past.

---

1. Core Business Model & How They Work

 [ Affiliated Physician Practices (~2,295 physicians, 37 states) ]
                     |
                     v
 [ Hospitals contract for NICU staffing / coverage, 1-3 yr terms ]
                     |
          ------------------------
          |                       |
          v                       v
 [ Professional Fees ]   [ Hospital Administrative /
   billed to payors        Medical Director Fees,
   (Medicaid, managed       Minimum Revenue Guarantees ]
   care, commercial) ]             |
          |                       |
          -----------> [ Net Revenue ] <-----

Pediatrix generates most of its revenue from professional fees for physician services, billed to third-party payors — heavily weighted toward state Medicaid programs given the population it serves (critically ill newborns and high-risk pregnancies), as well as managed care and commercial insurers. Hospitals supplement this with administrative fees (about 14% of 2025 net revenue), medical director fees, and in some contracts minimum revenue guarantees, reflecting the fact that 24/7 neonatal subspecialty coverage is a service hospitals need but often cannot staff themselves. Because many states restrict the corporate practice of medicine, Pediatrix operates through affiliated professional contractors — separate legal entities that actually employ or contract with the physicians — rather than employing clinicians directly.

---

2. Service Lines

                [ Pediatrix Medical Group ]
                          |
     -----------------------------------------------
     |                |                 |          |
[ Neonatal Care ] [ Maternal-Fetal] [ Other Pedi  [ Newborn
  NICU staffing/    Medicine:        Subspecialty: Hearing
  mgmt, >360          inpatient &    PICU (~60       Screening:
  hospitals, 32       office-based   hospitals),     793,000+
  states, ~1,350      high-risk      hospitalists    babies, 340
  neonatal MDs ]      pregnancy care  (50+ hospitals) hospitals ]

The company exited almost all office-based pediatric practices (other than maternal-fetal medicine) and its primary/urgent care line during 2024, concentrating instead on neonatal intensive care staffing/management, maternal-fetal medicine, pediatric intensive care, pediatric hospitalist services, pediatric surgery, newborn hearing screening, and telehealth/clinical research and education support.

---

3. Product Portfolio

---

4. Competitive Landscape

The filing does not name specific competitors by name, describing the competitive landscape generally: other health services companies and physician staffing groups compete for hospital contracts, hospitals increasingly consider employing neonatologists directly rather than contracting out, and private-equity-backed and healthcare-focused firms may enter the physician-staffing market, which has drawn increased scrutiny and investment in recent years.

          In-House Employment <----------------> Outsourced Physician Staffing
                  |                                        |
    Hospital directly employs                    Pediatrix Medical Group (MD)
    neonatologists (lower scale,                  national network, clinical
    harder recruiting for smaller                 data infrastructure, quality
    hospitals)                                    programs
                  |                                        |
    Smaller regional physician staffing groups / PE-backed entrants

---

5. Strategic Strengths & Risks

Strengths: Pediatrix's scale — roughly 2,295 affiliated physicians including about 1,350 neonatologists across 37 states, staffing NICUs at over 360 hospitals — gives it a national footprint in a subspecialty that is genuinely difficult to recruit and schedule for at a local level, particularly for smaller and mid-sized hospitals. Its clinical data warehouse (2.1 million+ patients, ~37 million patient-days) supports quality, research, and education programs that reinforce its value proposition to hospital partners, and its BabySteps platform carries HITRUST security recognition. Long-standing relationships with roughly 400 hospitals provide a base of recurring, contract-renewal-driven revenue.

Risks: The business is heavily exposed to government reimbursement — state Medicaid programs, which typically pay materially lower rates than private insurance, are a disproportionate payor given the neonatal/high-risk population served. Hospital contracts are typically short (one to three years) and generally terminable without cause, meaning Pediatrix must continually defend and renew its hospital relationships, and administrative fees from hospitals can be reduced. The company carries meaningful legal and regulatory exposure: indemnification obligations tied to physician malpractice, fraud-and-abuse law exposure (Anti-Kickback Statute, Stark Law, False Claims Act), uncertain enforceability of physician non-compete agreements, and corporate-practice-of-medicine restrictions that constrain its operating structure. A 2024 shift to a hybrid in-house/third-party revenue cycle management model introduces near-term execution risk.

---

6. Financial Overview

Note: Consolidated revenue, net income, and balance sheet figures for FY2025 were not available from the Item 1/1A business-description portion of the 10-K reviewed; figures above reflect operating and market-value data disclosed in that same section.

---

7. Summary Conclusion

Pediatrix's moat comes from being the scaled, trusted, data-backed staffing partner for a clinical specialty — neonatal and maternal-fetal medicine — that most hospitals cannot efficiently build and manage in-house. Its recent strategic refocusing away from lower-margin office-based pediatric practice lines sharpens that positioning but also narrows its revenue base, making its performance more tightly tied to NICU/maternal-fetal demand, Medicaid reimbursement policy, and hospital contract renewal cycles than in its earlier, more diversified era.